Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma
Citations Over TimeTop 10% of 2015 papers
Abstract
In order to determine the diagnostic and prognostic value of miR-26a in Cholangiocarcinoma (CCA), we compared miR-26a levels in serum from 66 CCA patients and 66 healthy controls, which was followed by serum analysis between the pre-operative serum and post-operative serum of these CCA patients. We found the concentration levels of miR-26a in serum of CCA patients were significantly higher than that from healthy controls (P < 0.01). Furthermore, the concentration levels of miR-26a in the post-operative serum were significantly reduced when compared to the pre-operative serum (P < 0.001). High miR-26a in serum was correlated significantly with clinical stage, distant metastasis, differentiation status, and poor survival of CCA patients. More importantly, serum miR-26a was an independent prognostic marker for CCA. In conclusion, our results suggested that miR-26a in serum might be a potential and useful noninvasive biomarker for the early detection of CCA.
Related Papers
- Circulating miR-122-5p as a potential novel biomarker for diagnosis of acute myocardial infarction.(2015)
- → Serum matrix metalloproteinase-2: A potential biomarker for diagnosis of epilepsy(2016)17 cited
- Value of Detection of P53 Protein and Tumor Markers in Serum for Auxiliary Diagnosis of the Distant Metastasis of Digestive Malignant Neoplasm(2009)
- [The constrastive analysis on distant metastasis before and after radiotherapy of nasopharyngeal carcinoma].(2006)